| Literature DB >> 33765428 |
Samantha L Allison1, Erin M Jonaitis2, Rebecca L Koscik2, Bruce P Hermann2, Kimberly D Mueller3, Robert P Cary4, Yue Ma4, Howard A Rowley5, Cynthia M Carlsson6, Sanjay Asthana1, Henrik Zetterberg7, Kaj Blennow8, Barbara B Bendlin4, Sterling C Johnson9.
Abstract
This study examined the effect of neurodegeneration, and its interaction with Alzheimer's disease (AD) cerebrospinal fluid biomarkers, on longitudinal verbal learning and memory performance in cognitively unimpaired (CU) late middle-aged adults. Three hundred and forty-two CU adults (cognitive baseline mean age = 58.4), with cerebrospinal fluid and structural MRI, completed 2-10 (median = 5) cognitive assessments. Learning and memory were assessed using the Rey Auditory Verbal Learning Test (RAVLT). We used sequential comparison of nested linear mixed effects models to analyze the data. Model selection preserved a significant ptau181/Aβ42 × global atrophy × age interaction; individuals with less global atrophy and lower ptau181/Aβ42 levels had less learning and delayed recall decline than individuals with more global atrophy and/or higher levels of ptau181/Aβ42. The hippocampal volume × age × ptau181/Aβ42 interaction was not significant. Findings suggest that in a sample of CU late middle-aged adults, individuals with AD biomarkers, global atrophy, or both evidence greater verbal learning and memory decline than individuals without either risk factor. Published by Elsevier Inc.Entities:
Keywords: Cerebrospinal fluid biomarkers; Global atrophy; Hippocampus; Preclinical Alzheimer's disease; Verbal learning; Verbal memory
Mesh:
Substances:
Year: 2021 PMID: 33765428 PMCID: PMC8286465 DOI: 10.1016/j.neurobiolaging.2021.01.030
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 5.133